Abacavir-Lamivudin-Mepha 600 mg/300 mg, Filmtabletten
7680670640015
CH-67064
Filmtabletten
Associated product:
Abacavir-Lamivudin-Mepha 600 mg/300 mg, Filmtabletten
1 / 3
google
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Tablette(n)
- Galenic form
- Filmtabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
abacavirum
|
600.0 MG | Substance | Wirkstoff (Principe actif) |
|
lamivudinum
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
hydroxypropylcellulosum
|
- | Substance | HNIDK |
|
carboxymethylamylum natricum A
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
hypromellosum
|
- | Substance | HNIDK |
|
macrogolum 4000
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
E 172 (rubrum)
|
- | Substance | FTODK |
|
natrium
|
3.276 MG | Substance | HBESI |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 67064
- Drug name
- Abacavir-Lamivudin-Mepha, Filmtabletten
- Galenic form
- FILM
- ATC Code
- J05AR02
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 04/07/2018
- Authorization expiration date
- 01/10/2026
- IT Number
- 08.03.0.
- Domain
- Human medicine
Package details
- Description (FR)
- ABACAVIR LAMIVUDIN Mepha Lactab 600/300mg 30 pce
- Description (DE)
- ABACAVIR LAMIVUDIN Mepha Lactab 600/300mg 30 Stk
- Market launch
- 04/07/2018
- Market withdrawal
- 29/06/2026
- Narcotic (BTM)
- No
Available generics (1)
Abacavir Lamivudin Sandoz, Filmtabletten
GTIN: 7680666870013
CHF 268.95